Company recalls sodium chloride for injection

Mar 07, 2022 - 03:12 PM
fda-alert-recall-compounded-drugs

B. Braun Medical Inc. has recalled five lots of 0.9% sodium chloride for injection due to fluid leakage or low fill volume, which could pose an infection risk to patients, the Food and Drug Administration announced last week. The company has not received reports of any adverse events. Hospitals and other facilities should immediately stop using the recalled products, and may report any adverse reactions or quality problems to the FDA’s MedWatch program.

Related News Articles

Headline
AHA provides recommendations to Consumer Product Safety Commission on modernized product injury surveillance system
The AHA Aug. 12 provided comments to the Consumer Product Safety Commission on its agenda and priorities for fiscal years 2027 and 2028, specifically…
Headline
Highest FDA recall issued for certain convenience kits
The Food and Drug Administration Aug. 3 identified Class I recalls of two convenience kit products. Certain kits by Medline…
Headline
FDA identifies, issues Class 1 recalls
The Food and Drug Administration has identified a recall by Cook Medical of Zenith Alpha 2 Thoracic Endovascular Graft proximal components after Cook Medical…
Headline
FDA issues early alerts for certain Baxter, Abiomed products
The Food and Drug Administration has issued early alerts for certain Spectrum infusion pumps from Baxter and Abiomed Automated Impella Controllers. The agency…
Headline
FDA approves first semiannual HIV prevention drug
The Food and Drug Administration has approved a new, first-of-its-kind semiannual HIV prevention medication, Gilead Sciences announced June 18. The company…
Headline
White House announces tariffs on goods imported from Canada, Mexico, China
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China. The tariffs for Mexico and Canada have since been delayed…